Scalable Biological Clock for Metabolic Disease Prediction Using the Phenome India Cohort

Background and study aim

The medRxiv record is titled “A Scalable Biological Clock for Metabolic Disease Prediction from the Phenome India Cohort.” The title indicates the authors aimed to develop a biological clock intended for metabolic disease prediction using data from the Phenome India Cohort. No abstract, introduction, or study aim text was included in the provided source material beyond the title.

Authorship and institutional affiliations

The preprint lists a large multi‑institutional author group and names the Phenome India Consortium. Lead and contributing authors represent multiple Indian research centers and universities, including but not limited to Ashoka University (Trivedi School of Biosciences and Koita Centre for Digital Health), CSIR‑Institute of Genomics and Integrative Biology, CSIR‑Centre for Cellular and Molecular Biology, CSIR‑National Chemical Laboratory, and other CSIR institutes. The DOI provided in the record is https://doi.org/10.64898/2026.08.29.26361656.

Preprint status and interpretation caution

This record is presented on medRxiv as a preprint. The medRxiv entry explicitly notes that the article has not been peer reviewed and therefore should not be used to guide clinical practice. This caution is part of the source record and applies to any clinical or implementation decisions based on the preprint.

Available information from the supplied source

From the supplied content we can reliably extract only: the full title, the author list and affiliations as presented on the medRxiv page, the DOI, and the preprint status. The supplied source did not include the manuscript body (abstract, methods, results, figures, tables, or discussion). Consequently, the following are verifiable from the source material:

• There is a research preprint that asserts development of a scalable biological clock for predicting metabolic disease.
• The work involves the Phenome India Cohort and a multi‑institutional team (Phenome India Consortium).
• The document is available on medRxiv with the noted DOI and carries the platform’s standard unrefereed preprint disclaimer.

Missing study details not reported in the source

The provided source content does not report the core scientific content of the manuscript. Specifically, the following elements were not available in the supplied material and therefore cannot be summarized or assessed here:

• Study design (cross‑sectional, longitudinal, cohort definition) and enrollment criteria.
• Sample size, demographic breakdown, and clinical characteristics of the Phenome India Cohort participants used for analysis.
• Data types and features used to build the biological clock (for example, clinical measures, biochemical markers, genomics, metabolomics, imaging, or electronic health record phenotypes) — not reported.
• Modeling approach, algorithm(s) or statistical methods employed, and procedures for training, tuning, and preventing overfitting.
• Internal or external validation strategy, including any held‑out test sets or independent cohorts.
• Performance metrics (for example, area under the curve, sensitivity, specificity, calibration) and comparisons with existing risk models — not reported.
• Reproducibility materials (code, data availability statements) and ethical approvals — not reported in the supplied text.
• Any specific claims about clinical utility, scalability in routine practice, or proposed deployment pathways — not reported.

Because these critical elements are absent from the supplied source excerpt, no judgment about the model’s validity, performance, or readiness for clinical translation can be made from the provided material.

Implications and next steps

From the medRxiv record we can state the following pragmatic points for clinicians, researchers, and policymakers who encounter this preprint:

• Treat findings as preliminary. The medRxiv entry carries the standard unrefereed preprint notice; clinical decisions should not be based on this record alone.

• Consult the full manuscript. To evaluate the methods, results, and potential applicability of the proposed biological clock for metabolic disease prediction, readers need access to the complete preprint text, including methods, results, validation, and limitations. Those elements were not provided in the supplied source extract.

• Await peer review and external validation. For any predictive model, especially those proposed for broad or scalable deployment, independent validation and peer review are necessary before clinical use.

• Contact authors or consortium for data and materials. The medRxiv page includes author and affiliation information; interested parties may follow up with corresponding authors or the Phenome India Consortium for access to the manuscript, preprint PDF, data availability statements, or code repositories if those are provided in the full submission.

Summary

The supplied medRxiv page documents a preprint titled “A Scalable Biological Clock for Metabolic Disease Prediction from the Phenome India Cohort,” authored by a large, multi‑institutional Indian research group and the Phenome India Consortium, and assigned DOI https://doi.org/10.64898/2026.08.29.26361656. The record is clearly labeled as unreviewed. The supplied content included only metadata (title, author list, affiliations, DOI) and did not include the manuscript text, abstract, methods, results, or conclusions. All substantive study details, performance metrics, and implementation claims were not reported in the supplied source and therefore are not summarized here.